CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- CT ORDER Other Confidential Order
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement
- 4 Open-market buy Chief Financial Officer bought 750 shares at an average $8.95 ($6,714)
- 4 Open-market buy President & CEO bought 2,000 shares at $8.50 ($16,997)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 1,000 shares at $7.96 ($7,959)
- 4 Open-market buy Director bought 1,700 shares at an average $8.00 ($13,602)
- 4 Open-market buy CSO/CMO bought 1,250 shares at $8.02 ($10,025)
- 4 Open-market buy Chief Financial Officer bought 1,250 shares at $7.97 ($9,961)
- 4 Open-market buy President & CEO bought 14,600 shares at an average $8.01 ($116,941)
- 4 Open-market buy Director bought 3,500 shares at an average $7.88 ($27,570)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- CT ORDER Other Confidential Order
- 10-K Report Annual Report
Page 39 of 50 · 1,000 filings